Leukocyte and Platelet-Rich Fibrin (LPRF) Therapy & Leprosy: the Need for Caution and Research Among Marginalised Groups in Low Resource Settings
In: Medicina Internacia Revuo; Houghton, F., Moran Stritch, M., Tamang, K. and Winterburn, 2022, S. 86-91
Online
academicJournal
Zugriff:
This paper discusses the potential of Leukocyte and Platelet-Rich Fibrin Therapy (LPRF) to help treat ulcers and skin damage associated with leprosy. It warns that although LPRF may be a valuable and cost-effective treatment, it is crucial to understand potential resistance to haematologically based treatments. For physicians and health service staff operating within a biomedical paradigm, folk beliefs resisting such treatments may be inconsequential. However, research and education among marginalised and excluded populations is vital to overcome potential hesitancy and resistance to such treatments. ; yes
Titel: |
Leukocyte and Platelet-Rich Fibrin (LPRF) Therapy & Leprosy: the Need for Caution and Research Among Marginalised Groups in Low Resource Settings
|
---|---|
Autor/in / Beteiligte Person: | Houghton, Frank ; Winterburn, Michael ; Technological University of the Shannon: Midlands Midwest |
Link: | |
Zeitschrift: | Medicina Internacia Revuo; Houghton, F., Moran Stritch, M., Tamang, K. and Winterburn, 2022, S. 86-91 |
Veröffentlichung: | Universala Medicina Esperanto Asocio, 2022 |
Medientyp: | academicJournal |
ISSN: | 0465-5435 (print) |
DOI: | 20.500.12065/4470 |
Schlagwort: |
|
Sonstiges: |
|